Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: CNBC World

What happened

Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.

Key facts

  • Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
  • Reported by CNBC World and published Wed, 30 Sep 2026 22:40:47 UTC.

Why it matters

International stories like this one shape diplomacy, travel, energy supply and security decisions well beyond the country involved, which is why WorldPing tracks every update on it in one place.

What to watch next

  • Official statements or denials from the governments named
  • Whether other major newsrooms confirm the same details
  • Any follow-up decision, vote or deadline tied to the event

Sources

The original report was published by CNBC World. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at CNBC World

Related WorldPing coverage

Hacker News
WorldPing
Hacker News

Before pixels: Modular industrial dashboards

Article URL: https://unsung.aresluna.org/before-pixels-modular-industrial-dashboards/ Comments URL: https://news.ycombinator.com/item?id=49912792 Points: 56 # Comments: 11…

Brief by WorldPing · Original reporting by Hacker News